A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms

Strong clusterin immunostaining is highly specific for follicular dendritic cell tumor

Karen L. Grogg, William R. Macon, Paul J. Kurtin, Antonio G. Nascimento

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Clusterin, a glycoprotein implicated in many cellular functions including apoptosis, has recently been shown to be strongly expressed in follicular dendritic cell tumors, and to be absent or only weakly expressed in other dendritic cell tumors. Fascin has also been investigated as a potential marker of dendritic cell neoplasms. We evaluated staining for antibodies directed against these two antigens in 202 spindle cell tumors, including cases of follicular dendritic cell tumor (n = 14), interdigitating dendritic cell tumor (n = 7), leiomyosarcoma (n = 17), inflammatory myofibroblastic tumor (n = 13), inflammatory pseudotumor (n = 2), spindle cell thymoma (n = 17), synovial sarcoma (n = 11), fibrosarcoma (n = 14), liposarcoma (n = 27), gastrointestinal stromal tumor (n = 13), malignant fibrous histiocytoma (n = 18), angiomatoid fibrous histiocytoma (n = 4), angiosarcoma (n = 10), malignant peripheral nerve sheath tumor (n = 8), malignant melanoma (n = 16), and spindle cell carcinoma (n = 11). Among these spindle cell neoplasms, strong diffuse clusterin staining had an overall specificity of 93% and a sensitivity of 100% for follicular dendritic cell tumor. Clusterin staining was least reliable in distinguishing follicular dendritic cell tumor from spindle cell thymoma or malignant fibrous histiocytoma, but these are entities that usually can be distinguished by clinical and morphologic data. Rare cases of leiomyosarcoma, fibrosarcoma and angiosarcoma may show strong clusterin staining. Fascin staining was very nonspecific among spindle cell tumors and thus does not imply a dendritic cell lineage.

Original languageEnglish (US)
Pages (from-to)260-266
Number of pages7
JournalModern Pathology
Volume18
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

Follicular Dendritic Cells
Clusterin
Sarcoma
Neoplasms
Dendritic Cells
Staining and Labeling
Malignant Fibrous Histiocytoma
Hemangiosarcoma
Thymoma
Leiomyosarcoma
Fibrosarcoma
fascin
Surveys and Questionnaires
Plasma Cell Granuloma
Synovial Sarcoma
Liposarcoma
Gastrointestinal Stromal Tumors
Neurilemmoma
Cell Lineage
Melanoma

Keywords

  • Clusterin
  • Fascin
  • Follicular dendritic cell tumor
  • Immunohistochemistry
  • Sarcoma

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms : Strong clusterin immunostaining is highly specific for follicular dendritic cell tumor. / Grogg, Karen L.; Macon, William R.; Kurtin, Paul J.; Nascimento, Antonio G.

In: Modern Pathology, Vol. 18, No. 2, 02.2005, p. 260-266.

Research output: Contribution to journalArticle

@article{3d95e27deb5241a693aea685ee3f49e1,
title = "A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms: Strong clusterin immunostaining is highly specific for follicular dendritic cell tumor",
abstract = "Clusterin, a glycoprotein implicated in many cellular functions including apoptosis, has recently been shown to be strongly expressed in follicular dendritic cell tumors, and to be absent or only weakly expressed in other dendritic cell tumors. Fascin has also been investigated as a potential marker of dendritic cell neoplasms. We evaluated staining for antibodies directed against these two antigens in 202 spindle cell tumors, including cases of follicular dendritic cell tumor (n = 14), interdigitating dendritic cell tumor (n = 7), leiomyosarcoma (n = 17), inflammatory myofibroblastic tumor (n = 13), inflammatory pseudotumor (n = 2), spindle cell thymoma (n = 17), synovial sarcoma (n = 11), fibrosarcoma (n = 14), liposarcoma (n = 27), gastrointestinal stromal tumor (n = 13), malignant fibrous histiocytoma (n = 18), angiomatoid fibrous histiocytoma (n = 4), angiosarcoma (n = 10), malignant peripheral nerve sheath tumor (n = 8), malignant melanoma (n = 16), and spindle cell carcinoma (n = 11). Among these spindle cell neoplasms, strong diffuse clusterin staining had an overall specificity of 93{\%} and a sensitivity of 100{\%} for follicular dendritic cell tumor. Clusterin staining was least reliable in distinguishing follicular dendritic cell tumor from spindle cell thymoma or malignant fibrous histiocytoma, but these are entities that usually can be distinguished by clinical and morphologic data. Rare cases of leiomyosarcoma, fibrosarcoma and angiosarcoma may show strong clusterin staining. Fascin staining was very nonspecific among spindle cell tumors and thus does not imply a dendritic cell lineage.",
keywords = "Clusterin, Fascin, Follicular dendritic cell tumor, Immunohistochemistry, Sarcoma",
author = "Grogg, {Karen L.} and Macon, {William R.} and Kurtin, {Paul J.} and Nascimento, {Antonio G.}",
year = "2005",
month = "2",
doi = "10.1038/modpathol.3800294",
language = "English (US)",
volume = "18",
pages = "260--266",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - A survey of clusterin and fascin expression in sarcomas and spindle cell neoplasms

T2 - Strong clusterin immunostaining is highly specific for follicular dendritic cell tumor

AU - Grogg, Karen L.

AU - Macon, William R.

AU - Kurtin, Paul J.

AU - Nascimento, Antonio G.

PY - 2005/2

Y1 - 2005/2

N2 - Clusterin, a glycoprotein implicated in many cellular functions including apoptosis, has recently been shown to be strongly expressed in follicular dendritic cell tumors, and to be absent or only weakly expressed in other dendritic cell tumors. Fascin has also been investigated as a potential marker of dendritic cell neoplasms. We evaluated staining for antibodies directed against these two antigens in 202 spindle cell tumors, including cases of follicular dendritic cell tumor (n = 14), interdigitating dendritic cell tumor (n = 7), leiomyosarcoma (n = 17), inflammatory myofibroblastic tumor (n = 13), inflammatory pseudotumor (n = 2), spindle cell thymoma (n = 17), synovial sarcoma (n = 11), fibrosarcoma (n = 14), liposarcoma (n = 27), gastrointestinal stromal tumor (n = 13), malignant fibrous histiocytoma (n = 18), angiomatoid fibrous histiocytoma (n = 4), angiosarcoma (n = 10), malignant peripheral nerve sheath tumor (n = 8), malignant melanoma (n = 16), and spindle cell carcinoma (n = 11). Among these spindle cell neoplasms, strong diffuse clusterin staining had an overall specificity of 93% and a sensitivity of 100% for follicular dendritic cell tumor. Clusterin staining was least reliable in distinguishing follicular dendritic cell tumor from spindle cell thymoma or malignant fibrous histiocytoma, but these are entities that usually can be distinguished by clinical and morphologic data. Rare cases of leiomyosarcoma, fibrosarcoma and angiosarcoma may show strong clusterin staining. Fascin staining was very nonspecific among spindle cell tumors and thus does not imply a dendritic cell lineage.

AB - Clusterin, a glycoprotein implicated in many cellular functions including apoptosis, has recently been shown to be strongly expressed in follicular dendritic cell tumors, and to be absent or only weakly expressed in other dendritic cell tumors. Fascin has also been investigated as a potential marker of dendritic cell neoplasms. We evaluated staining for antibodies directed against these two antigens in 202 spindle cell tumors, including cases of follicular dendritic cell tumor (n = 14), interdigitating dendritic cell tumor (n = 7), leiomyosarcoma (n = 17), inflammatory myofibroblastic tumor (n = 13), inflammatory pseudotumor (n = 2), spindle cell thymoma (n = 17), synovial sarcoma (n = 11), fibrosarcoma (n = 14), liposarcoma (n = 27), gastrointestinal stromal tumor (n = 13), malignant fibrous histiocytoma (n = 18), angiomatoid fibrous histiocytoma (n = 4), angiosarcoma (n = 10), malignant peripheral nerve sheath tumor (n = 8), malignant melanoma (n = 16), and spindle cell carcinoma (n = 11). Among these spindle cell neoplasms, strong diffuse clusterin staining had an overall specificity of 93% and a sensitivity of 100% for follicular dendritic cell tumor. Clusterin staining was least reliable in distinguishing follicular dendritic cell tumor from spindle cell thymoma or malignant fibrous histiocytoma, but these are entities that usually can be distinguished by clinical and morphologic data. Rare cases of leiomyosarcoma, fibrosarcoma and angiosarcoma may show strong clusterin staining. Fascin staining was very nonspecific among spindle cell tumors and thus does not imply a dendritic cell lineage.

KW - Clusterin

KW - Fascin

KW - Follicular dendritic cell tumor

KW - Immunohistochemistry

KW - Sarcoma

UR - http://www.scopus.com/inward/record.url?scp=13244292224&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13244292224&partnerID=8YFLogxK

U2 - 10.1038/modpathol.3800294

DO - 10.1038/modpathol.3800294

M3 - Article

VL - 18

SP - 260

EP - 266

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 2

ER -